Cefuroxime Axetil Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 250 mg, 500 mg
Reference Brands: Ceftin(US)
Category:
ENT
Cefuroxime axetil is a cephalosporin antibiotic that inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins. It effectively treats respiratory, skin, and urinary tract infections. Benefits include rapid bacterial eradication, reduced symptoms, and prevention of complications, supporting effective infection management worldwide.
Cefuroxime Axetil Tablets is available in Tablets
and strengths such as 250 mg, 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefuroxime Axetil Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefuroxime Axetil Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefuroxime axetil tablets, marketed as Ceftin, are approved in the US by the FDA and in the EU via EMA for treating respiratory, skin, and urinary tract infections. Regulatory approval requires a comprehensive dossier, including clinical efficacy, safety data, manufacturing practices, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, enabling healthcare providers worldwide to effectively combat bacterial infections with high-quality formulations supported by regional regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing